Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 29 03:36PM ET
52.71
Dollar change
-3.13
Percentage change
-5.61
%
IndexRUT P/E- EPS (ttm)-3.31 Insider Own25.52% Shs Outstand43.12M Perf Week-3.51%
Market Cap2.15B Forward P/E- EPS next Y-2.54 Insider Trans-11.92% Shs Float32.11M Perf Month-5.40%
Income-131.16M PEG- EPS next Q-1.03 Inst Own78.35% Short Float14.77% Perf Quarter7.68%
Sales0.00M P/S- EPS this Y-77.18% Inst Trans-4.98% Short Ratio7.58 Perf Half Y25.26%
Book/sh6.45 P/B8.17 EPS next Y39.14% ROA-72.82% Short Interest4.74M Perf Year85.40%
Cash/sh6.31 P/C8.35 EPS next 5Y15.00% ROE-91.11% 52W Range26.38 - 60.92 Perf YTD30.96%
Dividend Est.- P/FCF- EPS past 5Y24.34% ROI-49.07% 52W High-13.48% Beta-1.45
Dividend TTM- Quick Ratio17.26 Sales past 5Y0.00% Gross Margin- 52W Low99.81% ATR (14)3.01
Dividend Ex-Date- Current Ratio17.26 EPS Y/Y TTM-2.66% Oper. Margin0.00% RSI (14)43.99 Volatility7.72% 5.17%
Employees42 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.12 Target Price74.25
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-92.64% Payout- Rel Volume1.95 Prev Close55.84
Sales Surprise- EPS Surprise-202.48% Sales Q/Q- EarningsNov 06 AMC Avg Volume625.39K Price52.71
SMA20-5.16% SMA50-1.29% SMA20011.75% Trades Volume1,226,573 Change-5.61%
Date Action Analyst Rating Change Price Target Change
Sep-03-24Initiated H.C. Wainwright Buy $70
May-10-24Initiated Robert W. Baird Outperform $72
Feb-05-24Initiated Piper Sandler Overweight $93
Jan-23-24Initiated Stifel Buy $63
Nov-21-23Resumed Guggenheim Buy $40
Sep-29-20Initiated Guggenheim Buy $8
Jan-10-20Initiated Craig Hallum Buy $8
Dec-23-19Initiated Oppenheimer Outperform $10
Feb-13-18Reiterated Maxim Group Buy $8 → $4
Nov-27-24 08:00AM
07:40AM
05:38AM
Nov-26-24 10:08AM
08:30AM
04:05PM Loading…
Nov-14-24 04:05PM
Nov-06-24 04:05PM
Oct-28-24 08:00AM
Oct-25-24 02:44PM
Oct-21-24 08:00AM
Oct-18-24 06:41PM
Oct-16-24 08:44AM
Oct-15-24 06:10PM
Oct-10-24 07:04PM
Oct-08-24 06:29PM
08:30AM Loading…
08:30AM
Oct-03-24 01:03PM
Sep-16-24 04:05PM
Sep-12-24 01:34AM
Aug-28-24 10:13AM
Aug-27-24 08:51PM
08:00AM
Aug-19-24 04:17PM
Aug-15-24 08:00AM
Aug-07-24 11:53PM
04:05PM
Jul-17-24 08:56AM
Jun-28-24 08:00AM
Jun-24-24 05:18PM
Jun-04-24 08:00AM
04:05PM Loading…
May-22-24 04:05PM
08:00AM
May-15-24 08:00AM
02:22AM
May-10-24 07:16AM
May-09-24 11:54PM
04:05PM
May-03-24 05:46AM
May-02-24 10:32PM
04:01PM
Apr-30-24 08:00AM
Apr-29-24 11:12AM
11:11AM
08:00AM
Apr-19-24 04:05PM
Apr-04-24 01:54AM
01:54AM
Mar-08-24 04:05PM
Mar-06-24 10:53PM
04:05PM
Feb-22-24 08:00AM
Feb-14-24 08:50AM
Feb-05-24 10:10AM
Feb-01-24 08:00AM
Jan-29-24 04:05PM
Jan-26-24 08:50AM
Jan-24-24 08:00AM
Jan-10-24 08:50AM
Jan-05-24 08:00AM
Dec-21-23 06:59PM
Dec-15-23 09:30AM
Dec-14-23 03:44PM
03:05PM
07:00AM
Dec-01-23 03:06AM
Nov-27-23 01:02PM
Nov-20-23 03:06PM
Nov-10-23 04:05PM
Nov-07-23 08:00AM
Nov-06-23 08:00AM
Nov-01-23 11:30AM
Oct-26-23 10:33AM
Oct-20-23 01:22PM
Oct-16-23 04:07PM
08:01AM
Oct-06-23 06:25PM
Oct-04-23 06:16PM
04:05PM
Oct-03-23 08:00AM
Oct-02-23 04:05PM
Sep-28-23 09:58AM
08:30AM
Sep-27-23 06:08PM
04:55PM
04:01PM
03:30PM
01:28PM
07:21AM
Sep-26-23 04:11PM
12:51PM
12:17PM
07:30AM
Sep-25-23 08:00AM
Aug-18-23 09:02PM
Aug-16-23 08:00AM
Aug-08-23 04:05PM
Jun-02-23 06:35PM
May-09-23 04:05PM
May-03-23 04:05PM
Apr-26-23 06:50AM
Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Abingworth Bioventures VII LPRule 144 AffiliateOct 21 '24Proposed Sale54.16949,33651,416,038Oct 21 04:30 PM
Abingworth Bioventures VII LPRule 144 AffiliateOct 07 '24Proposed Sale49.632,522,751125,204,132Oct 07 04:30 PM
Yen KristenSEE REMARKSOct 01 '24Sale49.433,108153,62781,465Oct 03 06:03 PM
Mackaness James HCHIEF FINANCIAL OFFICEROct 01 '24Sale49.438,077399,241119,172Oct 03 06:02 PM
Hirano Patricia CSEE REMARKSOct 01 '24Sale49.433,108153,627108,932Oct 03 05:55 PM
Anish BhatnagarCHIEF EXECUTIVE OFFICEROct 01 '24Sale49.4321,6331,069,306719,553Oct 03 05:53 PM
Yen KristenSEE REMARKSAug 29 '24Sale47.285,435256,99284,573Aug 30 06:36 PM
Yen KristenSEE REMARKSAug 28 '24Sale47.585,270250,75390,008Aug 30 06:36 PM
Mackaness James HCHIEF FINANCIAL OFFICERAug 29 '24Sale47.286,870324,845127,249Aug 30 06:35 PM
Mackaness James HCHIEF FINANCIAL OFFICERAug 28 '24Sale47.586,661316,938134,119Aug 30 06:35 PM
Hirano Patricia CSEE REMARKSAug 29 '24Sale47.285,435256,992112,040Aug 30 06:34 PM
Hirano Patricia CSEE REMARKSAug 28 '24Sale47.585,270250,753117,475Aug 30 06:34 PM
Anish BhatnagarCHIEF EXECUTIVE OFFICERAug 29 '24Sale47.2858,3912,760,995741,186Aug 30 06:33 PM
Anish BhatnagarCHIEF EXECUTIVE OFFICERAug 28 '24Sale47.5856,6132,693,712799,577Aug 30 06:33 PM
Vivo Opportunity, LLC10% OwnerAug 27 '24Sale48.73500,00024,365,0006,816,851Aug 29 07:36 PM
Vivo Opportunity, LLC10% OwnerAug 28 '24Sale47.35425,00020,123,7506,391,851Aug 29 07:36 PM
Vivo Opportunity, LLC10% OwnerAug 29 '24Sale47.22100,0004,722,0006,291,851Aug 29 07:36 PM
Yen KristenSEE REMARKSAug 06 '24Sale45.465,957270,78095,278Aug 07 06:57 PM
Yen KristenSEE REMARKSAug 05 '24Sale45.775,017229,618101,235Aug 07 06:57 PM
Mackaness James HCHIEF FINANCIAL OFFICERAug 06 '24Sale45.468,134369,736140,780Aug 07 06:56 PM
Mackaness James HCHIEF FINANCIAL OFFICERAug 05 '24Sale45.776,849313,466148,914Aug 07 06:56 PM
Hirano Patricia CSEE REMARKSAug 06 '24Sale45.465,977271,689122,745Aug 07 06:56 PM
Hirano Patricia CSEE REMARKSAug 05 '24Sale45.775,032230,305128,722Aug 07 06:56 PM
Anish BhatnagarCHIEF EXECUTIVE OFFICERAug 06 '24Sale45.4669,1313,142,398856,190Aug 07 06:55 PM
Anish BhatnagarCHIEF EXECUTIVE OFFICERAug 05 '24Sale45.7758,2132,664,298925,321Aug 07 06:55 PM
Yen KristenSEE REMARKSJul 01 '24Sale41.542,17090,13621,252Jul 03 06:00 PM
Mackaness James HCHIEF FINANCIAL OFFICERJul 01 '24Sale41.547,190298,65455,763Jul 03 05:58 PM
Hirano Patricia CSEE REMARKSJul 01 '24Sale41.542,17090,13648,754Jul 03 05:58 PM
Anish BhatnagarCHIEF EXECUTIVE OFFICERJul 01 '24Sale41.5419,256799,844133,534Jul 03 05:56 PM
Vivo Opportunity, LLC10% OwnerApr 29 '24Sale47.80750,00035,850,0007,668,093May 01 01:10 PM
Vivo Opportunity, LLC10% OwnerApr 30 '24Sale45.13351,24215,851,5517,316,851May 01 01:10 PM
Yen KristenSEE REMARKSApr 01 '24Sale41.342,21891,69423,422Apr 03 09:40 PM
Mackaness James HCHIEF FINANCIAL OFFICERApr 01 '24Sale41.345,175213,93762,953Apr 03 09:39 PM
Hirano Patricia CSEE REMARKSApr 01 '24Sale41.342,21891,69441,812Apr 03 09:37 PM
Anish BhatnagarCHIEF EXECUTIVE OFFICERApr 01 '24Sale41.3418,980784,645152,790Apr 03 09:36 PM
Yen KristenSEE REMARKSJan 25 '24Sale48.3039719,17525,640Jan 29 05:47 PM
Hirano Patricia CSEE REMARKSJan 25 '24Sale48.3083240,18643,142Jan 29 05:44 PM
Anish BhatnagarCHIEF EXECUTIVE OFFICERJan 25 '24Sale48.302,527122,054171,770Jan 29 05:42 PM
Hirano Patricia CSee RemarksDec 13 '23Sale38.794,885189,51321,333Dec 15 06:00 PM
Hirano Patricia CSee RemarksDec 14 '23Sale36.491,35949,58419,974Dec 15 06:00 PM
Yen KristenSee RemarksDec 13 '23Option Exercise2.5517,91645,64419,953Dec 14 07:57 PM
Yen KristenSee RemarksDec 12 '23Sale36.9519,913735,8742,037Dec 14 07:57 PM
Yen KristenSee RemarksDec 13 '23Sale37.7617,916676,5572,037Dec 14 07:57 PM
Anish BhatnagarChief Executive OfficerDec 11 '23Sale35.6793,4083,331,70124,297Dec 13 09:34 PM
Mackaness James HChief Financial OfficerDec 11 '23Option Exercise2.6015,00038,92544,610Dec 13 09:34 PM
Mackaness James HChief Financial OfficerDec 11 '23Sale36.4132,4821,182,82812,128Dec 13 09:34 PM